Global Oncology Cancer Drugs Market Report - Industry Trend & Analysis, Size, Share, Geography, Forecast, 2019 - 2027

Table of Content

Chapter 1       Introduction

• Report Description
• Scope of the Market
• Research Methodology

Chapter 2       Executive Summary

• Snapshot of the Market
• Primary Interview Details

Chapter 3       Market Overview

• Market Introduction and Scope
• Porter’s Five Forces Analysis
• PEST Analysis
• Key Trends and Future Outlook
• Competitive Landscape: Company Market Share Analysis
• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities

Chapter 4       Market Segments by Indication (Revenue, USD Billion, 2019 - 2027)

• Breast Cancer
• Prostate Cancer
• Liver Cancer
• Esophagus Cancer
• Lung Cancer
• Stomach Cancer
• Colorectal Cancer
• Cervical Cancer
• Kidney Cancer
• Bladder Cancer
• Other Cancers

Chapter 5       Market Segments by Region (Revenue, USD Billion, 2019 - 2027)

• North America
  • The U.S.
  • Mexico
  • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Belgium
    • Switzerland
    • Netherlands
    • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Taiwan
      • Singapore
      • Australia
      • Rest of Asia Pacific
      • Rest of the World (RoW)
        • Central & South America
        • Middle East
        • Africa

Chapter 6       Company Profiles (Overview, Business Strategies, Financials, Recent Developments)

• AbbVie Inc
• Amgen
• Astellas Pharma Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson (Janssen Global Services, LLC,)
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc
• Others